Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.

Allscripts and Microsoft have joined forces to design a new clinical research model that leverages the EHR and other technologies clinicians use when providing treatment. Veradigm — Allscripts’ payer ...

In less than three years, Allscripts’ open application programming interfaces have exchanged data more than one billion times, the largest documented use of modern APIs in healthcare, the company ...

CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency ...

Allscripts CEO Paul Black is stepping down effective immediately after almost a decade at the medical software vendor, the executive said on a Thursday call with investors. Black, who's been Allscript ...

Allscripts is changing its corporate name to Veradigm, to reflect the health IT company’s focus on growth across each of its market segments, including payers, life sciences and providers, according ...

CHICAGO (AP) — Electronic health records company Allscripts Healthcare Solutions Inc. said Thursday that it is considering strategic options that could include a sale of the company. “We are ...

Allscripts President and CEO Paul M. Black, hired in December 2012 to rescue the troubled EHR vendor, and other company executives sounded defensive and optimistic notes this week as they attempt to ...

Allscripts Healthcare Solutions CEO Paul Black is stepping down from the helm of the electronic health records vendor, he said on the company's Q1 2022 earnings call Thursday. Black, who has been CEO ...

Health IT solutions company Medfusion has officially terminated its contract with EHR giant Allscripts following a series of unresolved payment disputes, company officials announced Monday. Medfusion, ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.